Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Epidemiologic Study of KRAS Mutation in Brazilian Patients With Advanced or Metastatic Non Small Cell Lung Cancer

This study has been completed.
Sponsor:
Collaborator:
Laboratorio Progenetica
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00956280
First received: August 10, 2009
Last updated: May 11, 2010
Last verified: May 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2010
  Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)